Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage Cell Signaling Technology
PhosphoSitePlus
HomeAbout PhosphoSiteUsing PhosphoSiteCuration ProcessContact
NIH-logos NIGMS Logo NIAAA Logo NCI Logo NIH Logo
Protein Page:
FGFRL1 (human)
p Phosphorylation
ac Acetylation
me Methylation
m1 Mono-methylation
m2 Di-methylation
m3 Tri-methylation
ub Ubiquitination
sm Sumoylation
ne Neddylation
gl O-GlcNAc
ga O-GalNAc
pa Palmitoylation
ad Adenylylation
sn S-Nitrosylation
ca Caspase cleavage
sc Succinylation

Overview
FGFRL1 Has a negative effect on cell proliferation. Note: This description may include information from UniProtKB.
Protein type: Membrane protein, integral
Cellular Component: plasma membrane; integral to membrane
Molecular Function: heparin binding; fibroblast growth factor binding; fibroblast growth factor receptor activity
Biological Process: negative regulation of cell proliferation; fibroblast growth factor receptor signaling pathway; skeletal development
Reference #:  Q8N441 (UniProtKB)
Alt. Names/Synonyms: FGF homologous factor receptor; FGF receptor-like protein 1; FGFR-5; FGFR-like protein; FGFR5; FGFRL1; FGRL1; FHFR; Fibroblast growth factor receptor 5; Fibroblast growth factor receptor-like 1
Gene Symbols: FGFRL1
Molecular weight: 54,537 Da
Basal Isoelectric point: 9.79  Predict pI for various phosphorylation states
Select Structure to View Below

FGFRL1

Protein Structure Not Found.


STRING  |  Wikipedia  |  neXtProt  |  Protein Atlas  |  BioGPS  |  Scansite  |  Pfam  |  Phospho.ELM  |  Source  |  GeneCards  |  UniProtKB  |  Entrez-Gene  |  GenPept  |  Ensembl Gene  |  InnateDB


Modification Sites and Domains Show Modification Legend
Click here to view phosphorylation modifications only

Modification Sites in Parent Protein, Orthologs, and Isoforms Show Modification Legend
 

Show Multiple Sequence Alignment


 SS 

SS: The number of records in which this modification site was determined using site-specific methods. SS methods include amino acid sequencing, site-directed mutagenesis, modification site-specific antibodies, specific MS strategies, etc.


 MS 

MS: The number of records in which this modification site was assigned using ONLY proteomic discovery-mode mass spectrometry.


       human

 
0 1 T46-p QVARLGRtVRLQCPV
0 1 S167-p IARPVGSsVRLkCVA
0 1 K171-ac VGSsVRLkCVASGHP
0 1 K202-ac EAAEPRKkKWTLSLK
0 1 K275-ac CKVRSDVkPVIQWLk
0 1 K282-ac kPVIQWLkRVEYGAE
0 1 P462 APQHLLGPGPVAGPK
0 1 P464 QHLLGPGPVAGPKLY
0 1 V465 HLLGPGPVAGPKLYP
0 4 Y502-p KVHQHIHyQC_____
  mouse

 
T42 QVARLGRTVRLQCPV
S163 IARPVGSSVRLKCVA
K167 VGSSVRLKCVASGHP
K198 EASEHRKKKWTLSLK
K271 CKVRSDVKPVIQWLK
K278 KPVIQWLKRVEYGSE
S451-p APQHILAsGstAGPK
S453-p QHILAsGstAGPKLY
T454-p HILAsGstAGPKLYP
- gap
Home  |  Curator Login With enhanced literature mining using Linguamatics I2E I2E Logo Produced by 3rd Millennium  |  Design by Digizyme
©2003-2013 Cell Signaling Technology, Inc.